Ernest Zichal, DO
Vascular Surgery · Newport News, VANPI 1952613838
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $20,123 of the $28,005 with a category attached, or 71.9%. Medtronic accounts for 67.7% of it on its own, with 37 other manufacturers making up the rest. Reporting peaked in 2023 at $8,952 and has fallen 71.8% since, to $2,521 in 2025.
Across 638 payments — averaging $43.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$19K
- Silk Road Medical, Inc.$3K
- Inari Medical, Inc.$2K
- Stryker$849
- W. L. Gore & Associates, Inc.$559
- Shockwave Medical, Inc$459
- plus $3K from 32 others
What the payments were for
- Speaking & faculty fees$4001%
- Travel & lodging$7,48327%
- Food & beverage$20,12372%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(3 entities) | 414 | $18,957 |
| Silk Road Medical, Inc. | 30 | $2,543 |
| Inari Medical, Inc. | 57 | $1,709 |
| Stryker | 22 | $849 |
| W. L. Gore & Associates, Inc. | 12 | $559 |
| Shockwave Medical, Inc | 6 | $459 |
| Philips North America LLC | 1 | $400 |
| Imperative Care, Inc | 5 | $336 |
| Johnson & Johnson | 17 | $293 |
| Penumbra, Inc. | 9 | $288 |
| Pfizer | 11 | $207 |
| Boston Scientific | 7 | $190 |
| Bard Peripheral Vascular, Inc. | 7 | $135 |
| Acell, Inc. | 6 | $125 |
| Cook Medical LLC | 2 | $110 |
| Veryan Medical Incorporated | 1 | $110 |
| Kerecis Limited | 3 | $94 |
| Venclose Inc. | 2 | $68 |
| Intuitive Surgical | 1 | $63 |
| Olympus Corporation Of The Americas | 1 | $49 |
| Convatec Inc. | 3 | $47 |
| Bolton Medical Inc | 1 | $47 |
| Teleflex LLC | 2 | $39 |
| Integra Lifesciences Corporation | 2 | $38 |
| Misonix Inc | 2 | $34 |
| Chiesi USA, Inc. | 2 | $31 |
| Shape Memory Medical Inc. | 1 | $26 |
| Atricure, Inc. | 1 | $25 |
| Cardinal Health 200 LLC | 1 | $22 |
| Tactile Systems Technology Inc | 1 | $22 |
| Argon Medical Devices, Inc. | 1 | $20 |
| Abbott | 1 | $19 |
| Elutia, Inc. | 1 | $19 |
| Davol Inc. | 1 | $17 |
| Smith+Nephew | 1 | $16 |
| Angiodynamics, Inc. | 1 | $15 |
| Cordis US CORP. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDURANT IIS$7,042
- ENROUTE Transcarotid Neuroprotection System$2,094
- Valiant Captivia$1,328
- ENROUTE Transcarotid Stent System$1,062
- ENHANCE Transcarotid Peripheral Access Kit$1,062
- ENROUTE 0.014 Guidewire$1,062
- ENROUTE Transcarotid Stent$916
- HawkOne$819
- TurboHawk$703
- FLOWTRIEVER CATHETER, S$688
- CT THROMBECTOMY SYSTEM KIT$688
- Endurant$526
- (6554) Periph Vasc Undiv$400
- Heli-FX EndoAnchor System$173
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$173
- PRODIGY CATHETER$163
- SPY-PHI SYSTEM$149
- Indigo$118
- Penumbra Ruby Coil$118
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$116
How this compares
$28,005 in reported general payments places this provider in the 80th percentile of 143 vascular surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 25 | $17,966 |
| ClopidogrelClopidogrel Bisulfate | 122 | $830 |
| Atorvastatin Calcium | 20 | $137 |
| Pantoprazole Sodium | 12 | $82 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $53 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $293 | $17,96625 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 143 vascular surgery providers in Virginia.
Other vascular surgery in Newport News
- Adam SagarwalaNewport News$23K
- Djurabek BabadjanovNewport News$15K
- Sathish MohanNewport News$15K
- Donald MendozaNewport News$11K
- Jean PannetonVirginia Beach$1.3M
- John DeitrickRichmond$684K
- Rasesh ShahChesapeake$465K
- David DexterNorfolk$404K
- Samuel SteermanVirginia Beach$252K
- Joseph BabrowiczFairfax$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.